Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementiaZachary C. Rosenthal, Stephen J. Haggarty, Daniel M. Fass et al.|Scientific Reports|2024Cited by 11
Chemical Neurobiology of Progranulin-Deficient Frontotemporal DementiaAngela She|Digital Access to Scholarship at Harvard (DASH) (Harvard University)|2017Cited by 0